pancreatic2

Description

This is the same data as in 'pancreatic', with overall and progression-free survival calculated. Dates have been removed.

Usage

data("pancreatic2")

Format

A data frame with 41 observations on the following 4 variables.

pfs

Progression-free survival: Time from entry until disease progression. If no progression was observed, before death, the time to death is used.

os

Overall survival: Time from entry until death

status

This censoring indicator is 1 for all patients, since all patients died.

stage

a factor with levels LA (locally advanced) or M (metastatic)

References

Moss RA, Moore D, Mulcahy MF, Nahum K, Saraiya B, Eddy S, Kleber M, and Poplin EA (2012) A multi-institutional phase 2 study of imatinib mesylate and gemcitabine for first-line treatment of advanced pancreatic cancer. Gastrointestinal Cancer Research 5, 77 - 83.

Examples

data(pancreatic2)